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INTRODUCTION
Primary breast lymphoma is a rare neoplasm of the breast 
with an incidence of less than 0.6% of primary breast malignan-
cies. Distinguishing it from breast cancer is important given 
that their treatments differ radically [1]. Its low incidence is 
attributed to the relatively small amount of lymphoid tissue in 
the breast compared to other organs. Primary breast lympho-
ma is an even rarer neoplasm in the male breast. To the best of 
our knowledge magnetic resonance imaging (MRI) has not 
been used previously in the evaluation of breast lymphoma. 
We report a rare case of male breast lymphoma evaluated with 
MRI as well as with other conventional imaging modalities, 
confirmed with ultrasound guided core needle biopsy, and 
managed by chemo-radiotherapy.
CASE REPORT
A 48-year-old male presented with a unilateral palpable mass 
in the left breast. None of the risk factors for male breast cancer 
such as prior irradiation of the chest, exogenous estrogen treat-
ment, liver disease, hyperestrogenism, androgen deficiency or 
family history had been positive.
On routine mammography, there was a lobulated homoge-
nous well-circumscribed soft tissue mass in the left breast with 
a large axillary lymph node showing loss of central fatty hilum. 
No calcifications (micro/macro) could be detected.
Ultrasound (US) (Philips HD11XE; Philips Ultrasound, 
Andover, MA, USA; Probe: 12 to 3 Mhz Broadband linear array 
transducer) revealed a homogenous, lobulated, hypoechoic 
mass showing mildly increased vascularity (Figures 1, 2).
On conventional MRI (Philips MR Systems Achieva; Philips 
Medical Systems, The Netherlands; 1.5 T MRI machine), the 
lesion was seen as a well-defined lobulated lesion involving the 
superomedial and inferomedial quadrants of the left breast, 
measuring 3.8×3.5×2.8 cm, appearing isointense to muscle 
on T1- and mildly hyperintense to muscle on T2-weighted 
images (Figures 3, 4). The lesion was best delineated on fat 
suppressed T1-weighted images (T1 SPIR) and showed mild 
homogenous contrast enhancement and Type II perfusion 
curve, which indicates initial rapid or slow rise followed by a 
plateau in the delayed phase (Figure 5) on MRI suggestive of 
neoplastic etiology.
Primary breast lymphoma was the leading diagnosis in this 
case, based on the combination of clinical and imaging find-
ings. There was no evidence of abdominal or cervical lymph-
adenopathy. US-guided fine needle aspiration cytology followed 
by trucut biopsy (Figure 6) confirmed the diagnosis of diffuse 
large B cell lymphoma which was CD 20 positive on immu-
nohistochemical analysis (Figure 7).
The patient was followed-up for last 7 months and under-
went chemotherapy with cyclophosphamide, hydroxydoxoru-
bicin, vincristine and prednisone (CHOP) regimen-14 cycles, 
resulting in a significant reduction in the size of the mass on 
physical examination.
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Primary lymphoma of the breast is a rare occurrence because of 
the paucity of lymphoid tissue in the breast and is an even rarer 
entity in the male breast. Imaging, along with tissue diagnosis 
goes a long way in diagnosing breast lymphoma which has a 
significantly different management scheme than other breast 
neoplasms with respect to radio-chemotherapy rather than sur-
gical resection. We present a case of primary male breast lym-
phoma which was evaluated with magnetic resonance imaging 
as well as other conventional imaging modalities and was treat-
ed by chemotherapy with a 7-month follow-up.
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DISCUSSION
Primary breast lymphoma is rare with 293 cases reported in 
the literature [1]. The age of incidence has ranged from 9 to 85 
years old, while most frequently seen in the sixth decade. In 
developed countries, male breast cancer accounts for 1-5.7% of 
breast cancer cases and 0.2-1.5% of all cases of malignancies in 
males [2,3]. Forty-four percent of cases of breast lymphoma are 
primary, although 22% are manifestations of disseminated dis-
ease and 29% represent recurrence of preexisting lymphoma [4].
The clinical and histologic criteria for diagnosis of a primary 
breast lymphoma are as follows [5]: 1) a close association be-
tween breast tissue and infiltrating lymphoma; 2) no evidence 
Figure 1. High frequency ultrasound using 12 to 3 MHz broadband linear 
array transducer revealed a well-defined lobulated relatively homoge-
nous, hypoechoic mass.
Figure 3. T1-weighted MR image showing a well-defined isointense, 
lobulated lesion and maintained fat planes with the underlying pectoralis 
muscle.
Figure 2. On color Doppler, the lesion showed mild vascularity.
Figure 4. T2-weighted MR image showing a mildly hyperintense lesion 
compared to muscle. 
Figure 5. Dynamic MR imaging showing a Type II perfusion curve.ARareCaseofMalePrimaryBreastLymphoma 335
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of widespread lymphoma and no history of previous extra-
mammary lymphoma; and 3) documentation of the breast as 
the principal organ involved and the primary site.
The differentials considered on mammography were abscess/ 
hematoma and invasive ductal carcinoma. On US, abscess and 
hematoma could be differentiated from primary breast lym-
phoma by the lack of vascularity within these two entities [2]. 
On US, primary breast lymphoma usually presents as a soli-
tary, hypoechoic mass showing increased vascularity with no 
calcification or necrosis within [6]. Invasive ductal carcinoma, 
which is much more common than primary breast lymphoma, 
usually presents with a mass but also demonstrates one or more 
of the following: calcification, architectural distortion, and spic-
ulated margin. These features are rarely seen in primary breast 
lymphoma [3]. Metastatic disease to the breast, such as mela-
noma, lymphoma, sarcoma, lung cancer, and gastric carcino-
mas, although rare can have a similar appearance to primary 
breast lymphoma but are usually multiple and bilateral, whereas 
primary lesions of the breast are single and unilateral. In this 
case, metastatic disease was a rather low possibility in the differ-
ential diagnosis, as this mass was single and unilateral with no 
known primary malignancy. On MR spectroscopy, malignant 
breast lesions show prominent choline peak, which is not gen-
erally detectable in normal breast tissue [7]. Diffusion MRI has 
a role in the follow-up of patients with diffuse large B cell lym-
phoma on chemotherapy to determine tumor response [8].
Conventional and dynamic MRI has been helpful in deter-
mining the number of lesions, chest wall involvement, axillary 
lymph node involvement, and in predicting the nature of the 
lesions depending on their kinetics. On conventional MR im-
aging, lymphoid masses and myxoid fibroadenomas demon-
strate high signal intensity on T2-weighted image as these are 
solid, highly cellular masses [9]. It is uncommon for other breast 
Figure 7. Immunohistochemical study showing diffuse positivity of diffuse 
round cells for CD 20 (Immunohistochemical stain, ×600).
Figure 6. H& E stained image showing diffuse large B cell lymphoma 
(H&E, ×100).
neoplasms to show high signal on T2-weighted images, unless 
there is intralesional necrosis or a colloid type of ductal carci-
noma. On dynamic MRI, there was a rapid early enhancement 
followed by plateau in the delayed phase suggestive of Type II 
perfusion curve which is explained by the pattern of enhance-
ment of lymphoma which is usually mild to moderate sustained 
enhancement.
Primary breast lymphoma can be diagnosed by MRI based 
on its characteristic imaging features as a single, lobulated, uni-
lateral mass lesion, showing high signal intensity on T2-weighted 
imaging, mild to moderate homogenous enhancement, Type 
II perfusion curve, and lack of central necrosis with histologi-
cal diagnosis further assisting in characterizing the lesion and 
influencing treatment which includes radiotherapy and che-
motherapy. It is important to make an accurate diagnosis, as 
surgical resection is generally not needed and patients have a 
better prognosis than in cases of carcinoma of the breast or 
patients with extranodal lymphomas, where a multidisciplinary 
approach where combinations of surgery, radiotherapy, and 
chemotherapy is required [10].
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